A Study Investigating a Medicine to Improve Social Communication in Adolescents and Adults with Autism Spectrum Disorder (ASD).
Official Title
MapLight Study (IRIS Clinical Trial)Purpose
The purpose of this study is to investigate a medication intended to improve social communication in adolescents and adults with ASD.
Could this study be right for you?
- Have an autism diagnosis or suspect you have an autism diagnosis
- Have a caregiver or study partner willing to enroll in the study with you